NCT02160951View on ClinicalTrials.gov

Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Multiple Myeloma
Interventions
DRUG

LGH447

LGH447, QD

Trial Locations (4)

467-8602

Novartis Investigative Site, Nagoya

650-0017

Novartis Investigative Site, Kobe

602-8566

Novartis Investigative Site, Kyoto

701-1192

Novartis Investigative Site, Okayama

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY